Amarogentin suppresses cell proliferation and EMT process through inducing ferroptosis in colorectal cancer

Abstract Background Colorectal cancer (CRC) is one common tumor with the high death rate, and badly affects the normal lives of CRC patients. Amarogentin (AG) has been found to exhibit regulatory roles and join into the progression of multiple diseases. However, the regulatory impacts and associated...

Full description

Saved in:
Bibliographic Details
Main Authors: Chao Wang, Zihao You, Guoqing Zhou, Juanjuan Dong, Sihao Tong, Guoping Sun
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Gastroenterology
Subjects:
Online Access:https://doi.org/10.1186/s12876-025-03649-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571636522418176
author Chao Wang
Zihao You
Guoqing Zhou
Juanjuan Dong
Sihao Tong
Guoping Sun
author_facet Chao Wang
Zihao You
Guoqing Zhou
Juanjuan Dong
Sihao Tong
Guoping Sun
author_sort Chao Wang
collection DOAJ
description Abstract Background Colorectal cancer (CRC) is one common tumor with the high death rate, and badly affects the normal lives of CRC patients. Amarogentin (AG) has been found to exhibit regulatory roles and join into the progression of multiple diseases. However, the regulatory impacts and associated molecular mechanisms of AG in CRC progression keep unclear. Methods and results In this study, it was demonstrated that AG weakened CRC cell viability in a concentration- and time-dependent manner. In addition, AG accelerated cell apoptosis by triggering ferroptosis. The cell invasion and EMT process were restrained after AG treatment, but these impacts were reversed after Fer-1 addition. Moreover, it was uncovered that AG retarded Nrf2/HO-1/GPX4 activation. Additionally, AG modulated PTC cell viability and stimulated ferroptosis. At last, it was illustrated that AG suppressed tumor growth in vivo. Conclusion In conclusion, it was disclosed that AG suppressed cell proliferation and EMT process through inducing ferroptosis in CRC, and retarded Nrf2/HO-1/GPX4 activation. This discovery suggested that AG may be one effective drug for ameliorating CRC progression.
format Article
id doaj-art-1faa8ffce7e8400ba06ebaa43731fd1f
institution Kabale University
issn 1471-230X
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Gastroenterology
spelling doaj-art-1faa8ffce7e8400ba06ebaa43731fd1f2025-02-02T12:27:16ZengBMCBMC Gastroenterology1471-230X2025-01-012511910.1186/s12876-025-03649-wAmarogentin suppresses cell proliferation and EMT process through inducing ferroptosis in colorectal cancerChao Wang0Zihao You1Guoqing Zhou2Juanjuan Dong3Sihao Tong4Guoping Sun5Department of Oncology, The First Affiliated Hospital of Anhui Medical UniversityDepartment of Oncology, Chaohu Hospital of Anhui Medical UniversityDepartment of Oncology, Chaohu Hospital of Anhui Medical UniversityDepartment of Oncology, Chaohu Hospital of Anhui Medical UniversityDepartment of Oncology, Chaohu Hospital of Anhui Medical UniversityDepartment of Oncology, The First Affiliated Hospital of Anhui Medical UniversityAbstract Background Colorectal cancer (CRC) is one common tumor with the high death rate, and badly affects the normal lives of CRC patients. Amarogentin (AG) has been found to exhibit regulatory roles and join into the progression of multiple diseases. However, the regulatory impacts and associated molecular mechanisms of AG in CRC progression keep unclear. Methods and results In this study, it was demonstrated that AG weakened CRC cell viability in a concentration- and time-dependent manner. In addition, AG accelerated cell apoptosis by triggering ferroptosis. The cell invasion and EMT process were restrained after AG treatment, but these impacts were reversed after Fer-1 addition. Moreover, it was uncovered that AG retarded Nrf2/HO-1/GPX4 activation. Additionally, AG modulated PTC cell viability and stimulated ferroptosis. At last, it was illustrated that AG suppressed tumor growth in vivo. Conclusion In conclusion, it was disclosed that AG suppressed cell proliferation and EMT process through inducing ferroptosis in CRC, and retarded Nrf2/HO-1/GPX4 activation. This discovery suggested that AG may be one effective drug for ameliorating CRC progression.https://doi.org/10.1186/s12876-025-03649-wAmarogentinEMT processFerroptosisColorectal cancerNrf2/HO-1/GPX
spellingShingle Chao Wang
Zihao You
Guoqing Zhou
Juanjuan Dong
Sihao Tong
Guoping Sun
Amarogentin suppresses cell proliferation and EMT process through inducing ferroptosis in colorectal cancer
BMC Gastroenterology
Amarogentin
EMT process
Ferroptosis
Colorectal cancer
Nrf2/HO-1/GPX
title Amarogentin suppresses cell proliferation and EMT process through inducing ferroptosis in colorectal cancer
title_full Amarogentin suppresses cell proliferation and EMT process through inducing ferroptosis in colorectal cancer
title_fullStr Amarogentin suppresses cell proliferation and EMT process through inducing ferroptosis in colorectal cancer
title_full_unstemmed Amarogentin suppresses cell proliferation and EMT process through inducing ferroptosis in colorectal cancer
title_short Amarogentin suppresses cell proliferation and EMT process through inducing ferroptosis in colorectal cancer
title_sort amarogentin suppresses cell proliferation and emt process through inducing ferroptosis in colorectal cancer
topic Amarogentin
EMT process
Ferroptosis
Colorectal cancer
Nrf2/HO-1/GPX
url https://doi.org/10.1186/s12876-025-03649-w
work_keys_str_mv AT chaowang amarogentinsuppressescellproliferationandemtprocessthroughinducingferroptosisincolorectalcancer
AT zihaoyou amarogentinsuppressescellproliferationandemtprocessthroughinducingferroptosisincolorectalcancer
AT guoqingzhou amarogentinsuppressescellproliferationandemtprocessthroughinducingferroptosisincolorectalcancer
AT juanjuandong amarogentinsuppressescellproliferationandemtprocessthroughinducingferroptosisincolorectalcancer
AT sihaotong amarogentinsuppressescellproliferationandemtprocessthroughinducingferroptosisincolorectalcancer
AT guopingsun amarogentinsuppressescellproliferationandemtprocessthroughinducingferroptosisincolorectalcancer